524564 — Gayatri BioOrganics Income Statement
0.000.00%
Last trade - 00:00- IN₹494.00m
- IN₹857.30m
Annual income statement for Gayatri BioOrganics, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 0 | 0 | 0 | 16.7 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 0 | 0 | 0 | 0.798 | 0 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 6.09 | 4.96 | 4.96 | 24.4 | 5.32 |
| Operating Profit | -6.09 | -4.96 | -4.96 | -7.68 | -5.32 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -5.51 | -4.97 | -4.96 | -7.96 | -6.81 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -5.51 | -4.97 | -4.96 | -10.1 | -6.81 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 845 | -4.97 | -4.96 | -10.1 | -6.81 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 845 | -4.97 | -4.96 | -10.1 | -6.81 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.07 | -0.063 | -0.063 | -0.128 | -0.09 |